MedTrace Logo

Effect of Ketamine in Depressive Symptoms of Elderly Patients With Visual Impairment.

NCT03473431 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2019-02-28

No results posted yet for this study

Summary

the prevalence of depression in elderly is from 4 to 30% and is associated with a lower quality of life mayor medical comorbidity, and increased mortality. Although there are various treatments for depression in the elderly, the study of interventions in resistant depression is limited and there are few reports of the efficacy and safety profile of alternative interventions such as ketamine in the elderly. The final objective of the present study is to report the effects of a single infusion of ketamine on the depressive symptoms in patients undergoing ophthalmologic surgery

Conditions

Interventions

DRUG

Ketamine

single infusion of 0.5 mg / kg ketamine

OTHER

control

physiological solution at 0.9 % with the same physical characteristics of ketamine solution,

Sponsors & Collaborators

  • Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

    collaborator OTHER_GOV

  • Instituto Mexicano del Seguro Social

    lead OTHER_GOV

Principal Investigators

  • DULCE RASCON MARTINEZ, M.D · imss

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-15
Primary Completion
2018-06-30
Completion
2018-07-30

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03473431 on ClinicalTrials.gov